Desktop Site |
26 Apr 24 | 11:16 | Open
Equity SME Eq Drv Currency Commodity Corporates
Get Quote
Notices |
S&P BSE SENSEX 74,152.89 -186.55 -0.25 %
Corporate Announcement
  • Security Code524804
    CompanyAUROBINDO PHARMA LTD.
    Exchange Disseminated Time
     
     
     Board to consider FY17 Results & Dividend on May 29, 2017 | 5/17/2017 7:12:12 PM 
     Aurobindo Pharma Ltd has informed BSE that a Meeting of the Board of Directors of the Company will be held on May 29, 2017, inter alia, to consider and approve, the Audited Financial Results of the Company for the year ended March 31, 2017 and also to consider dividend, if any, for the financial year 2016-17.

    Further to the letter dated May 12, 2017 informing the closure of Trading Window of the Company from May 18, 2017 until 48 hours from the date of declaration of the Audited Financial Results of the Company for the year ended March 31, 2017, Company inform that trading window will be closed up to May 31, 2017 and shall be re-opened on June 01, 2017.    		 
     
    << Back  
     
Recently Viewed
Copyright@ 2015. All Rights Reserved. BSE Ltd.
(42) 26 Apr 24|11:16 (IST)